Hangzhou Dac Biotech Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Jul 2033
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 18 to 25, 2026 · next Dec 18
- 2 fees due Mar 3 to 26, 2027 · next Mar 3
- 2 fees due Apr 10 to 29, 2027 · next Apr 10
- 1 fee due May 5, 2027The maintenance fee for Charged linkers and their uses for conjugation (US 10,464,955) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
- 2 fees due Jun 5 to 10, 2027 · next Jun 5
- 1 fee due Jul 16, 2027The maintenance fee for Conjugates of cell binding molecules with cytotoxic agents (US 11,873,281) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
- 1 fee due Nov 12, 2027The maintenance fee for Hydrophilic linkers and ligand-drug conjugates thereof (US 10,646,585) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,399,941 | Conjugates of cell binding molecules with cytotoxic agents In force · USPTO record | In force | USPTO record | |
| US 10,131,682 | Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules In force · USPTO record | In force | USPTO record | |
| US 9,988,408 | Cytotoxic agents for conjugation to a cell binding molecule In force · USPTO record | In force | USPTO record | |
| US 10,683,314 | Charged linkers and their uses for conjugation In force · USPTO record | In force | USPTO record | |
| US 10,696,699 | Charged linkers and their uses for conjugation In force · USPTO record | In force | USPTO record | |
| US 10,696,700 | Charged linkers and their uses for conjugation In force · USPTO record | In force | USPTO record | |
| US 10,501,412 | Conjugates of cell binding molecules with cytotoxic agents In force · USPTO record | In force | USPTO record | |
| US 10,464,955 | Charged linkers and their uses for conjugation In force · USPTO record | In force | USPTO record | |
| US 11,873,281 | Conjugates of cell binding molecules with cytotoxic agents In force · USPTO record | In force | USPTO record | |
| US 11,834,406 | Conjugates of cell binding molecules with cytotoxic agents In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
14 pending